News und Analysen
Why UnitedHealth Stock Was Climbing on Wednesday
UnitedHealth (NYSE: UNH) stock was proving to be beneficial for investors' financial health on Hump Day. They were trading the big health insurance company's stock up by nearly 4% in late-session
XOMA Revenue Jumps 39% in Fiscal Q2
XOMA (NASDAQ:XOMA), a biotechnology royalty aggregator, reported second quarter results on August 13, 2025, for the period ending June 30. The company’s revenue (GAAP) reached $13.1 million for Q2
Adaptimmune Sales Jump 59 Percent
Adaptimmune Therapeutics Plc (NASDAQ:ADAP), a biotechnology company specializing in engineered T-cell therapies for cancer, released its second-quarter earnings on August 13, 2025, covering results
2 Top Artificial Intelligence Stocks to Buy Right Now
It's been another banner year for artificial intelligence (AI) stocks. As of this writing, leaders like Palantir Technologies and Advanced Micro Devices advanced 148% and 44% year to date,
If You're In Your 20's, Consider Buying These 3 Healthcare Stocks
If you are in your 20's you likely have more than four decades ahead of you to invest before hitting retirement. Some might suggest that now is the time to take an aggressive investment stance, but
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
Many income investors probably have mixed emotions about stocks with ultra-high dividend yields. On one hand, they love the tremendous income these stocks provide. On the other hand, they might
The 3 Things That Matter for Viking Therapeutics Now
Investing successfully in biopharmaceutical companies can sometimes require complicated calculations worthy of Albert Einstein's brain. That's because picking the right ones involves a variation of
EQS-News: Evotec SE reports H1 2025 results: Strong progress on strategy execution
TherapeuticsMD Swings to Profit in Q2
TherapeuticsMD (NASDAQ:TXMD), a specialty pharmaceutical company focused on women’s health products, released its second quarter results on August 12, 2025, reporting a swing to profitability, with
Theravance Sales Jump 83 Percent
Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue
Pulse Biosciences Cash Jumps in Q2
Pulse Biosciences (NASDAQ:PLSE), a medical device innovator focused on nanosecond pulsed field ablation (nsPFA) for treating various conditions, released its second-quarter 2025 results on August
If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today
Viking Therapeutics (NASDAQ: VKTX) investors have seen a handsome return over the past three years, and this demonstrates that the real battle over biopharmaceutical stocks is won in the lab and
EQS-News: Gerresheimer AG: Achim Schalk To Join the Gerresheimer Management Board
EQS-News: Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
Wondering how well you'd have done if you'd invested in pharmaceutical giant Pfizer (NYSE: PFE) three years ago and hung on? Well, I'm afraid the answer isn't pretty: If you'd investing $1,000 in
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
Pfizer (NYSE: PFE) has been a terrible investment over the past three years. Revenue and earnings have generally moved in the wrong direction, as the company has been unable to follow up on the
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today
Ah, 10 years ago. It was 2015, and selfie sticks and hoverboards were all over. Apple debuted its Apple Watch to much fanfare, and...perhaps you invested in shares of Zoetis (NYSE: ZTS) stock? If
RadNet Reports Record Q2 Revenue
RadNet (NASDAQ:RDNT) reported its Q2 2025 results on Aug. 11, 2025, posting record revenue of $498.2 million, up 8.4% year-over-year and record adjusted EBITDA (non-GAAP) of $81.2 million, up 12.3%
Massive News for AMD and Nvidia Stock Investors
In this video, I cover recent updates regarding Advanced Micro Devices (NASDAQ: AMD) and Nvidia. Watch the short video to learn more, consider subscribing, and click the special offer link below.
U.S. Reportedly Taking 15% Cut of NVDA and AMD China Sales
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the
BioCardia Narrows Loss in Fiscal Q2
BioCardia (NASDAQ:BCDA), a clinical-stage cell therapy company focused on treatments for heart disease, released its financial results for the second quarter of 2025 on August 11, 2025. The company
Agenus Posts 48% Q2 Revenue Miss
Agenus (NASDAQ:AGEN), a clinical-stage biotechnology company focused on developing cancer immunotherapies, reported its second quarter 2025 earnings on August 11, 2025. The company's revenue (GAAP)
Harvard Bioscience Tops Q2 Revenue Views
Harvard Bioscience (NASDAQ:HBIO), a provider of specialized laboratory technologies for biomedical and life sciences research, released its financial results for the second quarter of fiscal 2025 on
RadNet Posts Record Q2 Revenue Up 8%
RadNet (NASDAQ:RDNT), a major operator of outpatient diagnostic imaging centers, published its second quarter 2025 results on August 11, 2025. The company reported record revenue of $498.2 million
AppLovin Shares Jump as Revenue Continues to Surge. Is It Too Late to Buy the Stock?
AppLovin (NASDAQ: APP) once again held up to the short-seller scrutiny it's been under, with yet another quarter of surging revenue and profitability growth. The stock is now up more than 500% over